Q3: How far apart should I inject cagrilintide and tirzepatide
GHK-Cu (Copper Peptide) is a copper-binding tripeptide of glycyl-L-histidyl-L-lysine, supplied as a 100mg lyophilised powder vial for in vitro research use

The Canadian Peptide Research Society is one organization helping advance peptide science in Canada through: research collaboration education and training scientific conferences and knowledge sharing exploration of emerging clinical applications You can learn more about their work here: Current research efforts in Canada and internationally are focused on: developing peptide-based medications (e.g., metabolic and hormone therapies) understanding how peptides influence tissue repair and inflammation advancing drug discovery and personalized medicine However, in musculoskeletal medicine specifically: most research remains preclinical (animal and laboratory studies) high-quality human clinical trials are still limited What this means for patients: Peptide research is an active and evolving field, and Canada is contributing to its development
Lambert D, Benhayoun S, Adjalla C, Glot MM, Renkes P, Grard P, et al
Additionally, there is some discussion regarding the neuroprotective potential of AHK-Cu